
Kura Oncology is a biotechnology business based in the US. Kura Oncology shares (KURA) are listed on the NASDAQ and all prices are listed in US Dollars. Kura Oncology employs 127 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Kura Oncology stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – KURA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Kura Oncology stock price (NASDAQ: KURA)
Use our graph to track the performance of KURA stocks over time.Kura Oncology shares at a glance
Latest market close | $14.60 |
---|---|
52-week range | $10.41 - $19.93 |
50-day moving average | $13.80 |
200-day moving average | $14.62 |
Wall St. target price | $32.22 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.99 |
Buy Kura Oncology stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Kura Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kura Oncology price performance over time
Historical closes compared with the close of $14.6 from 2023-01-25
1 week (2023-01-20) | 4.81% |
---|---|
1 month (2022-12-27) | 30.01% |
3 months (2022-10-27) | -5.32% |
6 months (2022-07-27) | -10.26% |
1 year (2022-01-23) | N/A |
---|---|
2 years (2021-01-27) | -50.89% |
3 years (2020-01-27) | 24.57% |
5 years (2018-01-26) | 19.95 |
Kura Oncology financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -17.06% |
Return on equity TTM | -28.42% |
Profit margin | 0% |
Book value | $6.27 |
Market capitalisation | $982.2 million |
TTM: trailing 12 months
Kura Oncology share dividends
We're not expecting Kura Oncology to pay a dividend over the next 12 months.
Kura Oncology share price volatility
Over the last 12 months, Kura Oncology's shares have ranged in value from as little as $10.41 up to $19.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kura Oncology's is 0.8322. This would suggest that Kura Oncology's shares are less volatile than average (for this exchange).
Kura Oncology overview
Kura Oncology, Inc. , a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
Kura Oncology in the news
Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor
Kura Oncology Announces FDA Clearance of IND Application for KO-2806, a Next-Generation Farnesyl Transferase Inhibitor
An Intrinsic Calculation For Kura Oncology, Inc. (NASDAQ:KURA) Suggests It's 48% Undervalued
Frequently asked questions
What percentage of Kura Oncology is owned by insiders or institutions?Currently 2.71% of Kura Oncology shares are held by insiders and 109.193% by institutions. How many people work for Kura Oncology?
Latest data suggests 127 work at Kura Oncology. When does the fiscal year end for Kura Oncology?
Kura Oncology's fiscal year ends in December. Where is Kura Oncology based?
Kura Oncology's address is: 12730 High Bluff Drive, San Diego, CA, United States, 92130 What is Kura Oncology's ISIN number?
Kura Oncology's international securities identification number is: US50127T1097 What is Kura Oncology's CUSIP number?
Kura Oncology's Committee on Uniform Securities Identification Procedures number is: 50127T109
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert